SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (932)5/28/1997 2:22:00 PM
From: I. Luttichuys   of 1762
 
Hello Don, I am worried, basically, that maybe there is something troublesome in the CE9.1 data which is elucidating with respect to SmithKline sales, etc.
If such a scenario were true (and I am making an assumption here), it would not be something that would be problematic near term. I generally sell stocks not based on the price but on my feeling and understanding as it touches the company longer term and I am thinking I may see an opportunity somewhere up the road. I will always post my feelings with respect to IDPH and my movements with respect to the stock will always appear here. Short term I think we are great here but, I have another stock I feel more strongly about at the moment and in which I have accumulated a large position. I would like to have more of it (GCR). Also my position in IDPH was rather large so when I add these factors up, I take the risk of selling.
The whole thing will probably not look like a smart move for months but, I think that eventually it will when GCR and IDPH gains are weighed in the balance.
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext